Biotechnology Assets (Spain) Today
| BST Stock | 0.33 0.01 3.13% |
PerformanceModest
| Odds Of DistressAbove Average
|
Biotechnology Assets is trading at 0.33 as of the 23rd of March 2025, a 3.13% up since the beginning of the trading day. The stock's open price was 0.32. Biotechnology Assets has more than 60 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 23rd of December 2024 and ending today, the 23rd of March 2025. Click here to learn more.
Moving together with Biotechnology Stock
Moving against Biotechnology Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Biotechnology Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biotechnology Assets' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biotechnology Assets or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Ideas | (View all Themes) |
| Business Concentration | Biotech, IT, Computers, Biotechnology, Healthcare, Computing (View all Sectors) |
Biotechnology Assets SA (BST) is traded on Madrid Exchange in Spain and employs 33 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.64 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biotechnology Assets's market, we take the total number of its shares issued and multiply it by Biotechnology Assets's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biotechnology Assets operates under Healthcare sector and is part of Biotechnology industry. The entity has 48.35 M outstanding shares.
Check Biotechnology Assets Probability Of Bankruptcy
Ownership AllocationBiotechnology Assets holds a total of 48.35 Million outstanding shares. Biotechnology Assets SA retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Biotechnology Ownership Details
Biotechnology Assets Risk Profiles
Although Biotechnology Assets' alpha and beta are two of the key measurements used to evaluate Biotechnology Assets' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.64 | |||
| Semi Deviation | 2.66 | |||
| Standard Deviation | 3.69 | |||
| Variance | 13.6 |
Biotechnology Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biotechnology Assets without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Other Information on Investing in Biotechnology Stock
Biotechnology Assets financial ratios help investors to determine whether Biotechnology Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Assets security.